MOACM
VIVO

Mutual of America Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Mutual of America Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,169
Closed -$305K – 1488
2022
Q4 		$305K Buy
9,169
+466
+5% +$15K ﹤0.01% 1261
2022
Q3 		$274K Buy
8,703
+1,385
+19% +$44.8K ﹤0.01% 1266
2022
Q2 		$223K Buy
7,318
+1,044
+17% +$28.2K ﹤0.01% 1295
2022
Q1 		$163K Buy
6,274
+351
+6% +$8.35K ﹤0.01% 1414
2021
Q4 		$121K Buy
5,923
+143
+2% +$2.74K ﹤0.01% 1484
2021
Q3 		$111K Sell
5,780
-380
-6% -$7.58K ﹤0.01% 1502
2021
Q2 		$137K Buy
6,160
+398
+7% +$8.44K ﹤0.01% 1493
2021
Q1 		$151K Buy
5,762
+369
+7% +$8.77K ﹤0.01% 1445
2020
Q4 		$101K Buy
5,393
+195
+4% +$3.64K ﹤0.01% 1474
2020
Q3 		$88K Buy
5,198
+3,128
+151% +$60.8K ﹤0.01% 1421
2020
Q2 		$48K Buy
2,070
+193
+10% +$2.8K ﹤0.01% 1351
2020
Q1 		$16K Buy
1,877
+355
+23% +$2.99K ﹤0.01% 1536
2019
Q4 		$15K Sell
1,522
-59
-4% -$554 ﹤0.01% 1617
2019
Q3 		$15K Buy
1,581
+54
+4% +$569 ﹤0.01% 1608
2019
Q2 		$18K Buy
1,527
+318
+26% +$3.83K ﹤0.01% 1584
2019
Q1 		$21K Buy
1,209
+153
+14% +$2.54K ﹤0.01% 1516
2018
Q4 		$18K Buy
1,056
+251
+31% +$4.28K ﹤0.01% 1498
2018
Q3 		$12K Buy
805
+649
+416% +$10.1K ﹤0.01% 1601
2018
Q2 		$2K Buy
+156
New +$2.33K ﹤0.01% 1647
2016
Q4 		– Sell
-2,400
Closed -$46K – 1226
2016
Q3 		$46K Hold
2,400
– – ﹤0.01% 1185
2016
Q2 		$47K Buy
+2,400
New +$47.1K ﹤0.01% 1185

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mutual of America Capital Management's VIVO Position: Q1 2023 in Review

Mutual of America Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 9,169 shares — an estimated $305K sold.

Mutual of America Capital Management first reported a position in VIVO in Q2 2016 and held it in 21 quarters. The position peaked at $305K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Mutual of America Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Mutual of America Capital Management sold 9,169 Meridian Bioscience Inc shares in Q1 2023, an estimated $305K.
  • Mutual of America Capital Management first reported a position in Meridian Bioscience Inc in Q2 2016 and held it in 21 quarters.
  • Mutual of America Capital Management's Meridian Bioscience Inc position peaked at $305K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Mutual of America Capital Management's 13F filing for Q1 2023, filed 4 May 2023.